BOSTON, June 22, 2018 /PRNewswire/ -- Orig3n, a Boston-based biotech company pioneeringthe future of health through genetics and regenerative medicine, today announced that its co-founders, Robin Y. Smith, CEO, and Kate Blanchard, COO, are finalists for the Ernest and Young
Smith and Blanchard were nominated as finalists by a panel of independent judges based on Orig3n's vision and mission to make personalized healthcare available to everyone. Award winners will be announced June 28.
"Orig3n is proud to be recognized as a leader at the forefront of the biotech industry," Smith said, "It's humbling to be honored amidst the notable business luminaries within the highly competitive New England region."
With a combined 35 plus years of experience in the regenerative medicine and consumer genetics industries, Orig3n has grown rapidly since its founding in 2014 under Smith's and Blanchard's leadership. Having secured more than $50 million in funding since 2014, Orig3n is leading the transformation in the understanding and treatment of rare, genetically inherited diseases and the movement to personalized health through breakthrough research and a line of direct-to-consumer health and wellness genetic tests.
"We are honored Orig3n's innovative work is being considered for this prestigious award," Blanchard said. "Through biotechnology focused on regenerative medicine and accessible personal genetics, individuals are more empowered than ever before to make informed decisions about their futures."
About Orig3n Inc.Orig3n exists at the intersection of biological science and emerging technology on a mission to create a better tomorrow for the future of medicine. As part of the mission to democratize health Orig3n empowers people by providing consumers direct, affordable access to information about their genes to help them make educated, proactive and personalized choices that may impact their well-being. That business enables Orig3n to invest in breakthrough cell therapy R&D by utilizing cutting-edge cellular science to develop personalized therapies for repairing tissue damage and disease. For more information, visit www.orig3n.com/our-mission/.
About Entrepreneur Of The Year®Entrepreneur Of The Year®, founded by EY, is the world's most prestigious business awards program for entrepreneurs, chosen from an independent panel of judges including entrepreneurs and prominent leaders from business, finance, and the local community. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities and more than 60 countries. www.ey.com/eoy
About EY's Growth Markets NetworkEY's worldwide Growth Markets Network is dedicated to serving the changing needs of high-growth companies. For more than 30 years, we've helped many of the world's most dynamic and ambitious companies grow into market leaders. Whether working with international mid-cap companies or early stage, venture-backed businesses, our professionals draw upon their extensive experience, insight and global resources to help your business succeed. For more information, please visit us at ey.com/sgm or follow news on Twitter: @EY_Growth.
About EYEY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by Ernst & Young LLP, a member of the global EY organization that provides services to clients in the US.
For more information, please visit www.ey.com
Contact: Nicole Grady Nicole.Grady@edelman.com (312) 240-2750
View original content:http://www.prnewswire.com/news-releases/orig3n-founders-named-finalists-for-ernest-and-young-entrepreneur-of-the-year-2018-award-300670866.html
SOURCE Orig3n Inc.
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All